OBJECTIVE: To evaluate myocardial protection using cardioplegia solution infused only antegradely or through a combined antegrade and retrograde route in patients undergoing surgery for ischemic or valvular heart disease. MATERIALS & METHODS: This Prospective comparative study included 108 consecutive patients who underwent cardiac surgery from March 2013 to October 2014 at Punjab Institute of Cardiology, Lahore Pakistan. Patients requiring coronary artery surgery, aortic valve replacement or combined aortic and mitral valve surgery were included. Patients requiring emergency surgery, undergoing CPR pre-operatively, requiring early re-exploration or patients with LV EF ≤30% were excluded. Data was analyzed using SPSS 20. P-value ≤ 0.05 was taken as significant. RESULTS: Out of 108 patients 70(64.81%) were male. The mean age of the patients was 39.62±16.15 year. Patients included 36 in CABG group, 36 in AVR and 36 in DVR group. Half of the patients in each group were delivered cardioplegia through antegrade route only and the other half were infused cardioplegia through combined antegrade and retrograde route. Significantly lower aortic cross clamp and cardio pulmonary bypass times were observed for both AVR and DVR. (p-value